A detailed history of Intellectus Partners, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Intellectus Partners, LLC holds 9,315 shares of JNJ stock, worth $1.45 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
9,315
Previous 8,854 5.21%
Holding current value
$1.45 Million
Previous $1.29 Million 16.62%
% of portfolio
0.39%
Previous 0.36%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$145.48 - $167.38 $67,066 - $77,162
461 Added 5.21%
9,315 $1.51 Million
Q2 2024

Jul 18, 2024

BUY
$144.38 - $157.78 $129,220 - $141,213
895 Added 11.25%
8,854 $1.29 Million
Q1 2024

May 03, 2024

BUY
$155.22 - $162.74 $136,127 - $142,722
877 Added 12.38%
7,959 $1.26 Million
Q4 2023

Feb 05, 2024

BUY
$145.6 - $158.88 $218,545 - $238,478
1,501 Added 26.89%
7,082 $1.11 Million
Q3 2023

Oct 25, 2023

BUY
$155.75 - $174.48 $57,939 - $64,906
372 Added 7.14%
5,581 $869,000
Q2 2023

Jul 31, 2023

BUY
$154.35 - $166.11 $8,643 - $9,302
56 Added 1.09%
5,209 $862,000
Q1 2023

May 04, 2023

BUY
$151.05 - $180.26 $1,963 - $2,343
13 Added 0.25%
5,153 $798,000
Q4 2022

Feb 02, 2023

SELL
$160.2 - $179.79 $130,562 - $146,528
-815 Reduced 13.69%
5,140 $907,000
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $702,753 - $781,989
-4,356 Reduced 42.25%
5,955 $973,000
Q2 2022

Aug 12, 2022

SELL
$168.19 - $186.01 $131,860 - $145,831
-784 Reduced 7.07%
10,311 $1.83 Million
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $47,916 - $54,415
-303 Reduced 2.66%
11,095 $1.97 Million
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $53,483 - $59,342
343 Added 3.1%
11,398 $1.95 Million
Q3 2021

Nov 16, 2021

BUY
$161.5 - $179.47 $631,303 - $701,548
3,909 Added 54.7%
11,055 $1.79 Million
Q2 2021

Aug 13, 2021

BUY
$159.48 - $171.07 $1,435 - $1,539
9 Added 0.13%
7,146 $1.18 Million
Q1 2021

May 17, 2021

SELL
$153.07 - $170.48 $36,124 - $40,233
-236 Reduced 3.2%
7,137 $1.17 Million
Q4 2020

Feb 18, 2021

BUY
$137.11 - $157.38 $951,406 - $1.09 Million
6,939 Added 1598.85%
7,373 $1.16 Million
Q4 2020

Feb 12, 2021

SELL
$137.11 - $157.38 $1 Million - $1.15 Million
-7,312 Reduced 94.4%
434 $1.16 Million
Q3 2020

Nov 16, 2020

SELL
$140.38 - $153.83 $21,197 - $23,228
-151 Reduced 1.91%
7,746 $1.15 Million
Q2 2020

Aug 14, 2020

SELL
$128.81 - $155.51 $175,310 - $211,649
-1,361 Reduced 14.7%
7,897 $1.11 Million
Q1 2020

May 14, 2020

BUY
$111.14 - $153.99 $91,023 - $126,117
819 Added 9.7%
9,258 $1.21 Million
Q4 2019

Jan 24, 2020

SELL
$127.5 - $146.44 $151,342 - $173,824
-1,187 Reduced 12.33%
8,439 $1.23 Million
Q3 2019

Oct 11, 2019

BUY
$126.95 - $142.14 $227,621 - $254,857
1,793 Added 22.89%
9,626 $1.25 Million
Q2 2019

Aug 08, 2019

BUY
$131.15 - $144.24 $113,575 - $124,911
866 Added 12.43%
7,833 $1.09 Million
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $20,115 - $22,366
-160 Reduced 2.24%
6,967 $974,000
Q4 2018

Feb 14, 2019

SELL
$122.84 - $147.84 $244,451 - $294,201
-1,990 Reduced 21.83%
7,127 $920,000
Q3 2018

Nov 15, 2018

SELL
$121.58 - $142.88 $72,704 - $85,442
-598 Reduced 6.16%
9,117 $1.26 Million
Q2 2018

Aug 14, 2018

SELL
$119.4 - $131.76 $457,302 - $504,640
-3,830 Reduced 28.28%
9,715 $1.18 Million
Q1 2018

May 15, 2018

SELL
$125.1 - $148.14 $116,217 - $137,622
-929 Reduced 6.42%
13,545 $1.74 Million
Q4 2017

Feb 13, 2018

SELL
$131.22 - $143.62 $285,272 - $312,229
-2,174 Reduced 13.06%
14,474 $2.02 Million
Q3 2017

Nov 14, 2017

SELL
$129.47 - $135.38 $28,224 - $29,512
-218 Reduced 1.29%
16,648 $2.16 Million
Q2 2017

Aug 15, 2017

BUY
N/A
16,866
16,866 $2.23 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Intellectus Partners, LLC Portfolio

Follow Intellectus Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intellectus Partners, LLC with notifications on news.